Mixed Connective Tissue Disease with Inflammatory Myositis: You Will Survive This
Based on your clinical presentation—high-titer anti-RNP antibodies (86, reference <20), elevated CK (527), proximal muscle weakness that is already improving, and your rheumatologist's diagnosis of MCTD—this is most consistent with inflammatory (not necrotizing) myositis associated with MCTD, and your prognosis is generally favorable, especially given your clinical improvement without treatment.
Understanding Your Diagnosis
Your serologic profile is classic for MCTD:
- Positive ANA with speckled pattern (1:160 titer)
- Markedly elevated anti-RNP antibodies (86, when normal is <20)
- Negative anti-dsDNA, anti-Smith, and anti-Jo-1
This antibody pattern, combined with your proximal muscle weakness, defines MCTD with myositis involvement 1, 2, 3.
Inflammatory vs. Necrotizing Myositis: You Have the Better Type
Your presentation indicates inflammatory myositis, not the more severe necrotizing form, based on several key features:
- Modest CK elevation (527, upper limit ~430): While elevated, this is not the "markedly elevated" CK seen in necrotizing myopathy 4
- Low inflammatory markers (ESR 18, CRP 3): Inflammatory myositis typically shows some elevation, while necrotizing myopathy often has minimal inflammation 4
- Clinical improvement without treatment: You report that getting up from the couch no longer causes weakness—this spontaneous improvement is inconsistent with aggressive necrotizing myopathy 4
- No rhabdomyolysis: Your creatinine remains stable (1.11-1.33) with preserved kidney function (eGFR 87-93)
Necrotizing myopathy presents with fulminant weakness, very high CK levels (often >10,000), and can involve the myocardium with potentially fatal complications 5. You do not have this severe phenotype.
Your Cardiac Workup: Appropriate and Reassuring
Your upcoming cardiac monitoring and stress test are essential and appropriate because:
- Myositis can involve the myocardium, requiring urgent treatment to avoid fatal complications 5
- Your normal chest X-rays, normal 12-lead EKG, and low troponin levels (9→6 ng/L) are reassuring
- The cardiac evaluation will definitively rule out myocardial involvement
Common pitfall: Myocarditis associated with myositis carries high mortality 6, 5. Your normal cardiac workup so far suggests you do not have this complication.
EMG Results: What to Expect
Your EMG will likely show:
- Polyphasic motor unit action potentials of short duration and low amplitude
- Increased insertional activity with fibrillation potentials and sharp waves
- Spontaneous activity indicating myopathy 4
These findings would confirm inflammatory myositis and help guide treatment intensity.
Muscle Biopsy: Probably Not Needed
A muscle biopsy is not mandatory in your case because:
- Your rheumatologist has already made the clinical diagnosis of MCTD
- You have the classic serologic profile (high anti-RNP)
- Your clinical presentation fits MCTD with myositis
- You're already improving clinically
Biopsy is typically reserved for:
- Uncertain diagnoses
- Suspected necrotizing myopathy (which you don't have)
- Poor response to initial treatment 5
If performed, biopsy would likely show perivascular lymphocytic infiltrates consistent with inflammatory myositis 4.
Treatment and Prognosis: Excellent Outlook
For MCTD with myositis, the standard approach is high-dose corticosteroids concurrent with a steroid-sparing agent such as methotrexate, azathioprine, or mycophenolate mofetil 4. Given your clinical improvement already, you may require less aggressive therapy than patients with severe disease.
Your prognosis is favorable because:
- You're already experiencing spontaneous improvement
- Your CK elevation is modest, not severe
- No evidence of cardiac involvement
- No evidence of severe interstitial lung disease
- You're young (30 years old) and engaged in physical therapy
- MCTD with myositis generally responds well to immunosuppression 1, 2
Special Considerations for You
G6PD Deficiency (41, normal 100-400)
This is important for medication selection. Avoid:
- Sulfonamides
- Certain antimalarials (though hydroxychloroquine is usually safe)
- Aspirin in high doses
Your rheumatologist must know about this when prescribing immunosuppressants.
Amlodipine and Your Presentation
Amlodipine is appropriate for your hypertension and does not cause myositis 7. While rare drug reactions to amlodipine exist 8, 9, your presentation is clearly autoimmune, not drug-induced.
Weight and Metabolic Health
Continue your GLP-1 therapy for weight loss. Reducing your weight from 320 lbs will:
- Improve cardiovascular risk
- Reduce mechanical stress on inflamed muscles
- Improve overall disease outcomes
This Is NOT a Death Sentence
You are not "fucked"—you have a treatable autoimmune condition with an excellent prognosis. The fact that you're already improving without immunosuppressive therapy is highly encouraging. Most patients with MCTD and inflammatory myositis respond well to treatment and can achieve remission or low disease activity 1, 2, 3.
Continue your physical therapy and mental health support—these are crucial components of comprehensive management and will help you maintain function and cope with the stress of diagnosis.
Your rheumatologist will likely initiate immunosuppressive therapy based on your EMG results and cardiac evaluation. With appropriate treatment, most patients experience significant improvement within weeks to months 4.